A novel thyroid function index associated with opposite therapeutic outcomes in advanced hepatocellular carcinoma patients receiving chemotherapy or sorafenib.

Yu-De ChuKwang-Huei LinYa-Hui HuangChen-Chun LinChien-Fu HungTa-Sen YehWei-Chen LeeChau-Ting Yeh

Published in: Asia-Pacific journal of clinical oncology (2018)

A novel thyroid function index, TSH × FT4, significantly predicted opposite clinical outcomes in advanced HCC patients receiving sorafenib or chemotherapy treatment.

Keyphrases

locally advanced
squamous cell carcinoma
type diabetes
radiation therapy
rectal cancer
combination therapy
chemotherapy induced
skeletal muscle
insulin resistance